[1] |
De Luca DA, Papara C, Vorobyev A, et al. Lichen sclerosus: The 2023 update[J]. Front Med(Lausanne), 2023, 10:1106318. doi: 10.3389/fmed.2023.1106318.
|
[2] |
Geisler AN, Koptyev J, Strunk A, et al. Quality of Life and Treatment Adherence in Patients with Vulvar Lichen Sclerosus[J]. Dermatology, 2023, 239(3):494-498. doi: 10.1159/000530108.
|
[3] |
Krapf JM, Mitchell L, Holton MA, et al. Vulvar Lichen Sclerosus: Current Perspectives[J]. Int J Womens Health, 2020, 12:11-20. doi: 10.2147/IJWH.S191200.
pmid: 32021489
|
[4] |
Bao Y, Li Z, Liu W, et al. Study of Langerhans cells and T lymphocytes in vulvar lichen sclerosus lesions[J]. Australas J Dermatol, 2021, 62(2):e217-e222. doi: 10.1111/ajd.13525.
pmid: 33326599
|
[5] |
Orszulak D, Dulska A, Niziński K, et al. Pediatric Vulvar Lichen Sclerosus-A Review of the Literature[J]. Int J Environ Res Public Health, 2021, 18(13):7153. doi: 10.3390/ijerph18137153.
|
[6] |
Corazza M, Schettini N, Zedde P, et al. Vulvar Lichen Sclerosus from Pathophysiology to Therapeutic Approaches: Evidence and Prospects[J]. Biomedicines, 2021, 9(8):950. doi: 10.3390/biomedicines9080950.
|
[7] |
Haefner HK, Welch KC, Rolston AM, et al. Genomic Profiling of Vulvar Lichen Sclerosus Patients Shows Possible Pathogenetic Disease Mechanisms[J]. J Low Genit Tract Dis, 2019, 23(3):214-219. doi: 10.1097/LGT.0000000000000482.
pmid: 31232912
|
[8] |
Tran DA, Tan X, Macri CJ, et al. Lichen Sclerosus: An autoimmunopathogenic and genomic enigma with emerging genetic and immune targets[J]. Int J Biol Sci, 2019, 15(7):1429-1439. doi: 10.7150/ijbs.34613.
pmid: 31337973
|
[9] |
Borghi A, D′Abundo L, Bassi C, et al. A microRNA signature to predict risk progression of vulvar lichen sclerosus to squamous cell carcinoma[J]. Br J Dermatol, 2023, 188(5):680-681. doi: 10.1093/bjd/ljad024.
pmid: 36738251
|
[10] |
Wang L, Lv Q, Guo J, et al. Transcriptome Profiling and Network Analysis Provide Insights Into the Pathogenesis of Vulvar Lichen Sclerosus[J]. Front Genet, 2022, 13:905450. doi: 10.3389/fgene.2022.905450.
|
[11] |
宋静卉, 邢丽媛, 王思思, 等. 外阴硬化性苔藓患者的生活质量及影响因素:基于198例成年女性问卷调查[J]. 皮肤性病诊疗学杂志, 2022, 29(4):311-316. doi: 10.3969/j.issn.1674-8468.2022.04.005.
|
[12] |
De Giorgi V, Scarfì F, Silvestri F, et al. Genital piercing: A warning for the risk of vulvar lichen sclerosus[J]. Dermatol Ther, 2021, 34(1):e14703. doi: 10.1111/dth.14703.
|
[13] |
Torres A, Zaborek-Łyczba M, Łyczba J, et al. The Importance of Immunological Disorders in the Pathogenesis of Lichen Sclerosus in Pediatric Patients: A Systematic Review[J]. Int J Mol Sci, 2022, 23(22):14212. doi: 10.3390/ijms232214212.
|
[14] |
Simms-Cendan J, Hoover K, Marathe K, et al. NASPAG Clinical Opinion: Diagnosis and Management of Lichen Sclerosis in Pediatric and Adolescent Patients[J]. J Pediatr Adolesc Gynecol, 2022, 35(2):112-120. doi: 10.1016/j.jpag.2021.09.008.
|
[15] |
Kraus CN. Vulvar Lichen Sclerosus[J]. JAMA Dermatol, 2022, 158(9):1088. doi: 10.1001/jamadermatol.2022.0359.
pmid: 35793083
|
[16] |
Burshtein A, Burshtein J, Rekhtman S. Extragenital lichen sclerosus: a comprehensive review of clinical features and treatment[J]. Arch Dermatol Res, 2023, 315(3):339-346. doi: 10.1007/s00403-022-02397-1.
|
[17] |
Mautz TT, Krapf JM, Goldstein AT. Topical Corticosteroids in the Treatment of Vulvar Lichen Sclerosus: A Review of Pharmacokinetics and Recommended Dosing Frequencies[J]. Sex Med Rev, 2022, 10(1):42-52. doi: 10.1016/j.sxmr.2021.03.006.
|
[18] |
Chin S, Scurry J, Bradford J, et al. Association of Topical Corticosteroids With Reduced Vulvar Squamous Cell Carcinoma Recurrence in Patients With Vulvar Lichen Sclerosus[J]. JAMA Dermatol, 2020, 156(7):813-814. doi: 10.1001/jamadermatol.2020.1074.
pmid: 32374363
|
[19] |
Heymann WR. Juvenile lichen sclerosus: A loss of innocence[J]. J Am Acad Dermatol, 2020, 82(2):301-302. doi: 10.1016/j.jaad.2019.11.012.
pmid: 31712176
|
[20] |
Singh N, Mishra N, Ghatage P. Treatment Options in Vulvar Lichen Sclerosus: A Scoping Review[J]. Cureus, 2021, 13(2):e13527. doi: 10.7759/cureus.13527.
|
[21] |
Tedesco M, Garelli V, Bellei B, et al. Platelet-rich plasma for genital lichen sclerosus: analysis and results of 94 patients. Are there gender-related differences in symptoms and therapeutic response to PRP?[J]. J Dermatolog Treat, 2022, 33(3):1558-1562. doi: 10.1080/09546634.2020.1854650.
|
[22] |
Gil-Villalba A, Ayen-Rodriguez A, Naranjo-Diaz MJ, et al. Laser Therapy for Vulvar Lichen Sclerosus, a Systematic Review[J]. Life(Basel), 2023, 13(11):2146. doi: 10.3390/life13112146.
|
[23] |
Borghi A, Corazza M. Novel Therapeutic Approaches and Targets for Treatment of Vulvar Lichen Sclerosus[J]. Curr Pharm Biotechnol, 2021, 22(1):99-114. doi: 10.2174/1389201021666200516154310.
|
[24] |
Mortensen OE, Christensen SE, Løkkegaard E. The evidence behind the use of LASER for genitourinary syndrome of menopause, vulvovaginal atrophy, urinary incontinence and lichen sclerosus: A state-of-the-art review[J]. Acta Obstet Gynecol Scand, 2022, 101(6):657-692. doi: 10.1111/aogs.14353.
|
[25] |
Jia R, Wu C, Tang X, et al. Comparison of the efficacy of focused ultrasound at different focal depths in treating vulvar lichen sclerosus[J]. Int J Hyperthermia, 2023, 40(1):2172220. doi: 10.1080/02656736.2023.2172220.
|
[26] |
Li R, Jiang J. The efficacy and safety of secondary focused ultrasound therapy for recurrence of non-neoplastic epithelial disorders of the vulva[J]. Int J Hyperthermia, 2022, 39(1):1310-1314. doi: 10.1080/02656736.2022.2131000.
|
[27] |
Liu J, Hao J, Wang Y, et al. Clinical and Dermoscopic Assessment of Vulvar Lichen Sclerosus After 5-Aminolevulinic Acid Photodynamic Therapy:A Prospective Study[J]. Photodiagnosis Photodyn Ther, 2021, 33:102109. doi: 10.1016/j.pdpdt.2020.102109.
|
[28] |
Wang Y, Hao J, Liu J. High-frequency ultrasound assessment of vulvar lichen sclerosus treated with photodynamic therapy[J]. Photodiagnosis Photodyn Ther, 2023, 41:103277. doi: 10.1016/j.pdpdt.2023.103277.
|
[29] |
van der Sluis N, Scheers E, Krenning G, et al. Autologous lipoaspirate as a new treatment of vulvar lichen sclerosus: A review on literature[J]. Exp Dermatol, 2022, 31(5):689-699. doi: 10.1111/exd.14561.
pmid: 35276020
|
[30] |
Matsumoto Videira H, Miguel Camargo M, Cesar Teixeira J, et al. Surgery as primary treatment improved overall survival in vulvar squamous cancer: A single center study with 108 women[J]. Eur J Obstet Gynecol Reprod Biol, 2024, 294:143-147. doi: 10.1016/j.ejogrb.2024.01.017.
pmid: 38244429
|
[31] |
Foster JA, Freeland D, Mauskar MM. Geriatric Genital Dermatology[J]. J Am Med Dir Assoc, 2024, 25(2):351-355. doi: 10.1016/j.jamda.2023.12.007.
|
[32] |
Morrel B, van der Avoort I, Ewing-Graham PC, et al. Long-term consequences of juvenile vulvar lichen sclerosus: A cohort study of adults with a histologically confirmed diagnosis in childhood or adolescence[J]. Acta Obstet Gynecol Scand, 2023, 102(11):1469-1478. doi: 10.1111/aogs.14668.
|